The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2024 / Dec / Redefining Sterile Manufacturing Standards with Kindeva
Discovery & Development Outsourcing Technology & Manufacturing Sponsored

Redefining Sterile Manufacturing Standards with Kindeva

12/06/2024 8 min read Video

Sponsored By

Kindeva

Share

Milton Boyer and Dave Stevens from Kindeva Drug Delivery delve into the company’s evolution and expertise in sterile manufacturing and drug delivery systems. Check out the video to find out more about their new, 200,000-square-foot facility in Bridgeton, which is designed to meet and exceed Annex 1 regulatory requirements, as well as how the company is responding to trends in green propellants for metered dose inhalers.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Strategic Development of Complex Oral Therapies
Formulation Small Molecules Development & Clinical
Strategic Development of Complex Oral Therapies

November 2, 2026

5 min read

Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies

Choosing a Sterile Fill-Finish Partner
Outsourcing
Choosing a Sterile Fill-Finish Partner

October 22, 2026

5 min read

Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner

Video Sitting Down With John Tomtishen
Outsourcing Cell & Gene Sitting Down With
Video: Sitting Down With… John Tomtishen

October 7, 2026

1 min read

Catalent’s John Tomtishen discusses his path into cell therapy and the evolving approaches to CMC, manufacturing, and commercialization

The Barriers Limiting Radiopharmaceutical Access
Outsourcing Supply Chain Interviews
The Barriers Limiting Radiopharmaceutical Access

September 21, 2026

5 min read

From isotope supply to reimbursement, the practical challenges shaping real-world delivery in oncology

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: